Dyno Therapeutics Ships AI-Designed Gene Delivery Vector

The biotech company launched Dyno-yp2, an AI-designed AAV vector for gene therapy — a quiet but significant milestone for AI in drug development.

Dyno Therapeutics launched Dyno-yp2, an AI-designed adeno-associated virus (AAV) gene delivery vector, as @SynBioBeta reported. AAV vectors are critical components in gene therapy — they deliver therapeutic genetic material to target cells — and designing effective ones has traditionally been a slow, empirical process.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae.

Unlock the full briefing

Get every story in today's briefing, the full archive, and the daily AI intelligence brief.

All stories today

Full archive

Daily brief